acridines has been researched along with Angiogenesis, Pathologic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bautista, D; Brabec, V; de Haro, C; Donaire, A; Kostrhunova, H; PĂ©rez, SA; Ruiz, J; Vicente, C; Zajac, J; Zamora, A | 1 |
Chang, YF; Chen, CC; Chen, WL; Chen, YL; Chou, CW; Huang, WC; Huang, WY; Lin, YC; Tzeng, CC; Wu, HA; Yang, PM | 1 |
2 other study(ies) available for acridines and Angiogenesis, Pathologic
Article | Year |
---|---|
New Acridine Thiourea Gold(I) Anticancer Agents: Targeting the Nucleus and Inhibiting Vasculogenic Mimicry.
Topics: Acridines; Angiogenesis Inhibitors; Antineoplastic Agents; Cell Line, Tumor; Cell Nucleus; Gold; Humans; Intercalating Agents; Molecular Mimicry; Neoplasm Invasiveness; Neovascularization, Pathologic; Thiourea | 2017 |
Loss of IKKbeta activity increases p53 stability and p21 expression leading to cell cycle arrest and apoptosis.
Topics: Acridines; Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Furans; HCT116 Cells; Humans; I-kappa B Kinase; Immunoblotting; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasms, Experimental; Neovascularization, Pathologic; Protein Stability; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Transplantation, Heterologous; Tumor Suppressor Protein p53 | 2010 |